|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018787,
umls-concept:C0021107,
umls-concept:C0034975,
umls-concept:C0055729,
umls-concept:C0087111,
umls-concept:C0205174,
umls-concept:C0332283,
umls-concept:C0392756,
umls-concept:C0441471,
umls-concept:C0475224,
umls-concept:C0547047,
umls-concept:C1322815,
umls-concept:C2348535
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-15
|
|
pubmed:abstractText |
Cilostazol has reduced restenosis and repeat intervention after drug-eluting stent (DES) implantation. However, there is little data regarding impact of cilostazol on cardiac events after DES implantation. Therefore, we assessed the long-term efficacy and safety of cilostazol in patients undergoing successful DES implantation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
pubmed-author:HongMyeong-KiMK,
pubmed-author:KimJae-JoongJJ,
pubmed-author:KimWon-JangWJ,
pubmed-author:KimYoung-HakYH,
pubmed-author:LeeCheol WhanCW,
pubmed-author:LeeJong-YoungJY,
pubmed-author:LeeSeung-WhanSW,
pubmed-author:ParkDuk-WooDW,
pubmed-author:ParkSeong-WookSW,
pubmed-author:ParkSeung-JungSJ,
pubmed-author:YunSung-CheolSC
|
|
pubmed:copyrightInfo |
Copyright (c) 2010 Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
159
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
284-291.e1
|
|
pubmed:dateRevised |
2010-9-15
|
|
pubmed:meshHeading |
pubmed-meshheading:20152228-Aspirin,
pubmed-meshheading:20152228-Drug Therapy, Combination,
pubmed-meshheading:20152228-Drug-Eluting Stents,
pubmed-meshheading:20152228-Female,
pubmed-meshheading:20152228-Follow-Up Studies,
pubmed-meshheading:20152228-Humans,
pubmed-meshheading:20152228-Male,
pubmed-meshheading:20152228-Middle Aged,
pubmed-meshheading:20152228-Myocardial Infarction,
pubmed-meshheading:20152228-Platelet Aggregation Inhibitors,
pubmed-meshheading:20152228-Tetrazoles,
pubmed-meshheading:20152228-Thrombosis,
pubmed-meshheading:20152228-Ticlopidine,
pubmed-meshheading:20152228-Time Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
|
|
pubmed:affiliation |
Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
